March 18th 2025
Debra Patt, MD, PhD, MBA, executive vice president of Public Policy and Strategy for Texas Oncology, said the practice received positive feedback from nurses and patients during a pilot that concluded in February.
CMS Outlines 3 New Drug Pricing Models Targeting Wide Scope of Therapies
Dr Dennis Scanlon Discusses IRA Part D Changes Intended to Expand Access